Electronic Caregiver Expands Access to Intelligent Care Across New Mexico While Advancing the Rio Grande Health Technology and Services Corridor
Electronic Caregiver, Inc. has achieved significant milestones in New Mexico, including Medicaid in-network provider status and approval under the state's Developmental Disabilities (DD) Waiver Program. These advancements, coupled with their enhanced Advanced Primary Care Management platform, expand access to intelligent care across the state. The company is actively working to establish New Mexico as a national center for healthcare technology through the "Rio Grande Health Technology and Services Corridor," fostering innovation and creating high-quality jobs.
GE HealthCare (GEHC) Introduces AI-Driven Upgrade Pathways to Modernize Legacy Imaging Suites
GE HealthCare (GEHC) has introduced new AI-driven upgrade pathways for its legacy Innova and Discovery interventional suites. These upgrades allow healthcare facilities to integrate advanced imaging innovations and AI-enabled workflows without requiring major construction. This initiative aims to extend the lifecycle of existing infrastructure, minimize disruption, and enhance operational efficiency with specialized tools and predictive maintenance services.
GE HealthCare (GEHC) Introduces AI-Driven Upgrade Pathways to Modernize Legacy Imaging Suites
GE HealthCare (GEHC) has launched new AI-driven upgrade pathways for its legacy Innova and Discovery interventional suites, aiming to modernize existing infrastructure without requiring extensive construction or full system replacements. These upgrades integrate advanced imaging innovations, AI-enabled workflows, and predictive maintenance services, enhancing procedural accuracy and operational efficiency. The initiative helps healthcare providers manage evolving clinical needs while minimizing disruption and extending the lifespan of their current medical imaging systems.
Labcorp chief legal officer Kyle sells $26,329 in common stock. By Investing.com
Labcorp's Chief Legal Officer, Kathryn W. Kyle, sold 92 shares of common stock for $26,329 on July 2, 2026, as part of a Rule 10b5-1 trading plan. This sale occurred while Labcorp shares were near their 52-week high. The transaction followed the vesting of 256 Restricted Stock Units, with some shares disposed of to cover tax obligations.
Clarivate to sell life sciences unit for $600 million
Clarivate Plc announced it will sell its Life Sciences & Healthcare segment to Altaris LLC for $600 million. The company plans to use the $500 million cash proceeds to reduce its $4.34 billion debt. Following the transaction, Clarivate will focus on its Academia & Government and Intellectual Property segments and reaffirmed its full-year 2026 financial outlook, which includes the divested segment's results until the close.
GE HealthCare stock holds steady after a thin session
GE HealthCare's stock remains steady, performing in line with its core imaging and diagnostics business. The company focuses on hospital imaging, ultrasound, and patient-monitoring systems, with its business model centered on selling imaging systems, diagnostics tools, and related services to hospitals and clinics. The article notes that no verified live quote was available, showing the share price at $0.00 as of the publication date.
Russell Growth Index Exit Could Be A Game Changer For Stryker’s (SYK) Investor Base
Stryker Corporation (NYSE: SYK) was recently removed from several major Russell growth indexes, including the Russell 1000 Growth, Russell Top 200 Growth, and Russell 3000 Growth benchmarks. This move is significant not for the company's underlying business fundamentals, but for how its stock might trade and who its investors will be. The upcoming Q2 2026 earnings webcast on July 30 will be key for investors to understand how Stryker is managing supply chain issues and input costs.
Earnings Preview: What To Expect From GE HealthCare Technologies’ Report
GE HealthCare Technologies (GEHC) is expected to report its Q2 earnings soon, with analysts projecting a slight decrease in Q2 diluted EPS but an overall increase for fiscal years 2026 and 2027. Despite underperforming the S&P 500 and the Health Care Select Sector SPDR ETF in the past year, the company recently declared a cash dividend and introduced AI-powered upgrade pathways for medical imaging systems. Analysts maintain a "Moderate Buy" rating with a potential upside of 21.6%.
Earnings Preview: What To Expect From GE HealthCare Technologies’ Report
GE HealthCare Technologies (GEHC) is set to release its Q2 earnings, with analysts expecting a diluted EPS of $1.04, a slight decrease from the previous year. Despite a 13.9% stock decline over the past 52 weeks, the company recently declared a quarterly dividend and introduced AI-powered imaging system upgrades, which analysts view positively, giving GEHC a "Moderate Buy" rating with a potential upside of 21.6%.
Global X HealthTech ETF (HEAL) ETF Holders - Institutional Ownership
This article provides details about the Global X HealthTech ETF (HEAL), including its current stock price, PE and PB ratios, volume, dividend yield, and top holdings. It notes that institutional ownership data and guru trades are not available without a premium membership. The page also offers investment tools and educational resources from GuruFocus.
GE HealthCare Technologies Inc. stock rises Thursday, outperforms market
Shares of GE HealthCare Technologies Inc. (GEHC) rose 1.09% to $65.57 on Thursday, outperforming the mixed stock market where the S&P 500 Index remained mostly unchanged and the Dow Jones Industrial Average saw a 1.14% increase. This marks the stock's second consecutive day of gains.
PHG - Koninklijke Philips NV ADR Volatility & Greeks
This article provides a detailed financial overview of Koninklijke Philips NV ADR (PHG), including its current stock performance, key financial metrics, EPS trends, and insider/institutional ownership data. It presents a snapshot of the company's market position, dividend information, and analyst recommendations.
General Electric Co (GE) Stock Price Quote Today & Current Price Chart | Capital.com EU
This article provides current stock information for General Electric Co (GE), including its stock price quote, trading conditions for CFDs, and key financial statistics. It highlights GE's recent transformation into three independent entities (GE Aerospace, GE Vernova, and GE HealthCare Technologies) and includes related news and user feedback about the trading platform. The content is primarily aimed at potential traders interested in GE stock through CFD instruments.
PHG - Koninklijke Philips NV ADR Earnings
This article provides a detailed financial overview of Koninklijke Philips NV (PHG) ADR, including its last closing price, market capitalization, income, sales, and various financial ratios. It also lists key performance indicators, insider/institutional ownership, and analyst recommendations.
GE HealthCare Technologies Inc. stock rises Wednesday, outperforms market
GE HealthCare Technologies Inc. (GEHC) saw its stock rise 1.33% to $64.86 on Wednesday, bucking a general market downturn where the S&P 500 Index and Dow Jones Industrial Average both fell. This increase ended a two-day losing streak for the company's shares.
Press Release: GE HealthCare Announces Cash Dividend for Second Quarter of 2026
GE HealthCare has announced a cash dividend for the second quarter of 2026. The dividend is set at $0.03 per share of common stock. It will be payable on August 15, 2026, to shareholders of record as of the close of business on August 1, 2026.
J&J's Supply Chain Innovation Supports Treatment Delivery
Johnson & Johnson secured ninth place in Gartner's 2026 Global Supply Chain Top 25 rankings, highlighting its operational excellence in ensuring reliable medicine availability amid global disruptions. The company's strategies include integrating suppliers as an extended network, implementing the Transcend program for end-to-end business process transformation, and deploying AI-powered digital assistants in manufacturing. These innovations aim to enhance supply chain resilience, improve patient access to treatments, and support consistent quality control, including a $1 billion investment in a new contact lens manufacturing and distribution facility in the US.
IIT Hyderabad partners with Silicon Labs to develop Made-in-India smart medical devices
IIT Hyderabad's Centre for Healthcare Entrepreneurship (CfHE) has collaborated with Silicon Labs to foster the development of smart medical devices in India. This partnership aims to equip medical device start-ups with cutting-edge semiconductor technologies, AI capabilities, and financial support, accelerating the creation of affordable and accessible healthcare solutions. The initiative seeks to strengthen India's deep-tech medical device ecosystem and translate research innovations into practical applications.
Price to book forward of GE HealthCare Technologies Inc. – NASDAQ:GEHC
This article provides financial data for GE HealthCare Technologies Inc. (NASDAQ: GEHC), specifically focusing on its price-to-book forward metric. It indicates that the market is currently closed with no trades. The content primarily serves as a data point for investors and analysts interested in GEHC's valuation.
GE HealthCare (GEHC) Announces Cash Dividend for Q2 2026
GE HealthCare (GEHC) has announced a cash dividend of $0.035 per share for Q2 2026, payable on August 14, 2026, to shareholders of record by July 24, 2026. The company is currently considered 24.6% undervalued according to GuruFocus's GF Value™ and shows strong insider buying activity, indicating confidence in its financial health and future prospects. This dividend reflects GE HealthCare's commitment to shareholder value and may attract income-focused investors.
GE HealthCare Technologies Inc. stock falls Tuesday, underperforms market
GE HealthCare Technologies Inc. (GEHC) stock dropped 1.60% to $64.01 on Tuesday, despite a strong overall market performance where the S&P 500 Index and Dow Jones Industrial Average both saw gains. This marked the second consecutive day of losses for the company's shares.
GE HealthCare Technologies declares $0.035 dividend
GE HealthCare Technologies has announced a dividend of $0.035 per share. This declaration signals the company's commitment to returning value to its shareholders. The specific dates for the dividend payment, such as ex-dividend and record dates, would typically follow this announcement.
Why Is JNJ Stock Defying The Market’s Daily Mood Swings?
Johnson & Johnson (JNJ) stock has shown remarkable independence from the S&P 500, with a low correlation of 0.18 over the past five years, making it a "shock absorber" in a portfolio. Despite recent strong performance and an ambitious growth outlook driven by its Innovative Medicine division and new drug ICOTYDE, the market remains somewhat skeptical of management's double-digit growth target. Investors are advised to consider JNJ's role in dampening portfolio swings rather than chasing short-term gains, with the success of ICOTYDE being a key indicator to watch.
Virtual care model helps CommonSpirit tackle nurse retention challenges
CommonSpirit Health has implemented a "Virtually Integrated Care" (VIC) model, utilizing proprietary technology, to address nurse retention challenges. This model connects virtual nurses with bedside teams to provide support, mentorship, and assistance with various tasks, leading to a 41% reduction in first-year registered nurse turnover. The success is attributed to in-house technology development and continuous stakeholder engagement.
GE Healthcare Technologies Inc. Declares Cash Dividend for the Second Quarter of 2026, Payable on August 14, 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) has declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026. This dividend is payable on August 14, 2026, to shareholders of record as of July 24, 2026. The announcement was made on June 30, 2026, and also noted by MT Newswires, confirming the quarterly dividend amount.
Stryker (SYK) Stock After Recent Pullback And DCF Upside Potential
Stryker (SYK) stock has seen mixed performance recently, with an 8.5% rise over the last week but a 15.6% decline year-over-year. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 12.8%, with an intrinsic value of $379.17 per share against its current price of $330.52. However, its Price-to-Earnings (P/E) ratio of 37.97x is higher than the industry average, indicating it might be overvalued by this metric when compared to Simply Wall St's Fair Ratio of 31.39x.
GE Healthcare Technologies Keeps Quarterly Dividend at $0.035 a Share, Payable Aug. 14 to Holders of Record July 24
GE Healthcare Technologies announced it will maintain its quarterly dividend at $0.035 per share. Shareholders of record by July 24 will be eligible to receive this dividend, which is payable on August 14. This news comes amidst other recent updates for the company, including new product introductions and analyst ratings.
GE HealthCare sets 3.5-cent dividend for Aug. 14 payment
GE HealthCare Technologies Inc. (Nasdaq: GEHC) has declared a cash dividend of $0.035 per share for the second quarter of 2026. This dividend is payable on August 14, 2026, to shareholders of record as of July 24, 2026. The company, a global healthcare solutions provider, stated this decision was made by its Board of Directors.
GEHC Launches Allia Upgrade Pathways for Interventional Suites
GE HealthCare Technologies Inc. (GEHC) has introduced Allia platform upgrade pathways, allowing healthcare providers to modernize existing Innova and Discovery Image Guiding Solutions (IGS) systems. These upgrades integrate advanced AI-enabled workflows and imaging technologies without requiring significant infrastructure changes, addressing growing procedural complexity and aging equipment. Despite the announcement, GEHC shares saw a slight decline, but the initiative is expected to strengthen its position in the interventional imaging market by offering a cost-effective modernization strategy.
GE HealthCare announces cash dividend for second quarter of 2026
GE HealthCare Technologies Inc. (Nasdaq: GEHC) has declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026. This dividend is payable on August 14, 2026, to shareholders of record as of July 24, 2026. GE HealthCare, a leading global healthcare solutions provider, noted its commitment to delivering innovative medical technology and AI-driven solutions.
GE HealthCare Boosts Interventional Suites with Allia Upgrades
GE HealthCare has introduced new upgrade pathways for its Innova and Discovery image guiding solutions (IGS) systems, allowing customers to modernize with Allia technologies. These upgrades aim to improve efficiency, decision-making, and extend the life of interventional rooms by preserving existing infrastructure and minimizing clinical disruption. The pathways offer access to AI-enabled features like CleaRecon DL, 3DStent, and OmnifyXR, alongside proactive maintenance tools like Tube Watch and OnWatch Predict.
GE Healthcare names Akshar Awalgaonkar as Chief Procurement Officer
GE HealthCare has appointed Akshar Awalgaonkar as its new Chief Procurement Officer. Awalgaonkar, an Indian American executive with 20 years of experience, will lead the company's global procurement strategy to enhance operational excellence and supply chain resilience. He joins GE HealthCare from Avery Dennison, where he served as Group Vice President and Chief Procurement Officer.
GE HealthCare adds upgrade pathways for existing Allia interventional imaging systems
GE HealthCare has introduced new upgrade pathways for its Innova, Discovery, and Allia Image Guided Solutions (IGS) systems. These upgrades allow hospitals to modernize existing interventional imaging suites with the latest Allia software, workflows, and imaging technologies without full replacement. The initiative aims to extend the life of equipment, reduce construction needs, and minimize disruptions, addressing the challenge of aging imaging infrastructure in healthcare facilities.
Why CONMED (CNMD) Shares Are Falling Today
CONMED (NYSE:CNMD) shares fell 4.9% after BofA Securities downgraded the stock to Underperform from Neutral, citing concerns about future growth and lowering its 2027 organic growth and EPS estimates. The firm maintained a $40.00 price target. This follows an earlier drop linked to a U.S. Commerce Department investigation into medical equipment imports that could lead to tariffs.
GE HealthCare Technologies Inc. stock falls Monday, underperforms market
GE HealthCare Technologies Inc. (GEHC) stock fell by 1.08% to $65.05 on Monday, despite a general upward trend in the broader market. The S&P 500 Index and the Dow Jones Industrial Average both saw gains, indicating GE HealthCare's underperformance. This decline ended a four-day winning streak for the company's stock.
Is AbbVie (ABBV) One of the 10 Best July Dividend Stocks to Buy?
AbbVie Inc. (ABBV) is set to trade ex-dividend on July 15, qualifying it as one of the top July dividend stocks. The company recently received FDA approval for Skyrizi to treat pediatric psoriasis patients, expanding its market. While acknowledging ABBV's investment potential, the article suggests that certain AI stocks offer greater promise for higher and faster returns.
GE HealthCare offers upgrade paths for legacy imaging systems
GE HealthCare has announced upgrade pathways for its legacy Innova and Discovery Image Guiding Solutions systems to its Allia platform. These upgrades allow healthcare providers to modernize existing interventional X-ray equipment, preserving infrastructure and minimizing construction, while integrating advanced technologies and workflows. The company also announced that the MIM Contour ProtégéAI+ 2.0 software received 510(k) clearance from the U.S. Food and Drug Administration, showcasing additional advancements in its medical technology offerings.
BMO Capital Upgrades American Homes (AMH) to Outperform
BMO Capital has upgraded American Homes 4 Rent (NYSE:AMH) to Outperform from Market Perform, maintaining a $39 price target. The upgrade is attributed to the removal of "worst-case regulatory scenarios" with bipartisan support for the 21st Century Road to Housing Act, which preserves the status quo for build-for-rent. BMO Capital also noted attractive valuation levels and gradually improving fundamentals for AMH.
Is Real Brokerage (REAX) the Best High Growth Penny Stock to Buy?
The Real Brokerage Inc. (NASDAQ:REAX) has reached a significant milestone, surpassing 35,000 agents across the United States and Canada, with CEO Tamir Poleg highlighting the company's focus on agent success. The company recently added entrepreneur JP Piccinini as a Growth Leader and expanded its presence in key New York markets by incorporating NOVEM Real Estate. While recognizing REAX's potential, the article suggests that certain AI stocks may offer higher and quicker returns.
GE HealthCare offers upgrade paths for legacy imaging systems By Investing.com
GE HealthCare announced upgrade pathways for select legacy Innova and Discovery Image Guiding Solutions systems to its Allia platform, allowing healthcare providers to modernize existing interventional X-ray equipment. These upgrades provide access to Allia technologies and workflows, supporting procedural efficiency and offering various advanced features. The company, valued at $29.91 billion by market cap, has also recently received FDA clearance for its MIM Contour ProtégéAI+ 2.0 software and had its stock receive various analyst ratings.
Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings Amid Impressive ROE and Expanding Diagnostic Portfolio
Lantheus Holdings, Inc. (LNTH) is a strong player in the healthcare sector, particularly in diagnostic and therapeutic products, indicated by its $7.15 billion market cap and robust stock performance. The company exhibits impressive financial health with a 23.48% Return on Equity and substantial free cash flow, despite a modest revenue growth. Analysts maintain overwhelmingly positive ratings, supported by an innovative product portfolio and strategic collaborations, positioning LNTH for future growth in precision medicine.
GE HealthCare lets hospitals modernize aging imaging suites without major construction
GE HealthCare has introduced Allia platform upgrade pathways to help hospitals modernize older interventional imaging systems without needing major construction. These upgrades aim to extend the life of existing infrastructure, minimize disruption, and provide access to advanced technologies, including AI-enabled features and augmented reality solutions. This initiative addresses the challenge of aging equipment in healthcare by offering a more sustainable and less disruptive modernization approach.
GE HealthCare introduces Allia upgrade pathways designed to modernize existing interventional suites
GE HealthCare has launched Allia platform upgrade pathways to help modernize existing Innova and Discovery Image Guiding Solutions (IGS) systems. These upgrades allow customers to access the latest Allia technologies and workflows, supporting efficiency and procedural decision-making while preserving existing infrastructure and minimizing disruption. The initiative aims to extend the lifespan of interventional suites, address aging equipment, and support long-term operational and sustainability goals.
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
Insight Molecular Diagnostics Inc. (iMDx) announced that its Chief Science Officer, Prof. Dr. Ekkehard Schuetz, has published his 200th scientific article. Dr. Schuetz is a co-inventor of the dd-cfDNA testing technology used in iMDx’s GraftAssure assays and is recognized as a top researcher globally. His extensive work has significantly advanced molecular diagnostic testing for transplanted organ rejection, with recent studies published in leading medical journals.
Resilient Lending Programs Assert American Express Company (AXP) as a Stock to Buy for Good Returns
American Express Company (AXP) is presented as a strong stock pick due to its resilient lending programs. Recent performance metrics for May 2026 show healthy consumer and small business card balances, with a low net write-off rate for principal. Although the article suggests other AI stocks might offer higher returns, AXP's stable position as a globally integrated payments company with diverse services is highlighted.
Navan (NAVN) Selected by Cummins to Support Global Business Travel
Navan, Inc. (NASDAQ:NAVN) has been selected by Cummins (CMI) to manage the business travel needs for its 60,000+ employees across more than 60 countries. This partnership follows Navan's recent collaboration with Enbridge (ENB) and strong Q1 results, which led BMO Capital to raise Navan's price target to $30 with an Outperform rating. The company's AI-powered software platform is recognized for simplifying travel and expense management, contributing to efficiency and growth.
Kulicke and Soffa Industries (KLIC) Up More Than 13% Over the Past Month, Here’s Why
Kulicke and Soffa Industries (KLIC) has seen a significant surge of over 13% in the past month, reaching an all-time high, driven by strong fiscal Q2 2026 earnings. The semiconductor assembly equipment provider exceeded revenue and EPS expectations, attributing growth to a 93% sequential increase in its memory segment and strong demand for NAND technology. The company also provided optimistic Q3 2026 guidance, expecting $310 million in revenue and $1.00 non-GAAP EPS.
Here’s What B. Riley Thinks About FormFactor (FORM)
B. Riley analyst Craig Ellis upgraded FormFactor (FORM) to Buy, maintaining a $165 price target, after the stock experienced a 14% decline post-analyst day. Ellis believes the decline is an overreaction given the company's strong fundamentals and growth. FormFactor, a semiconductor testing equipment provider, recently gained 3.6% and was added to the Russell 1000 index, with analysts expecting a 13% upside.
GE HealthCare (GEHC) To Show Cloud Imaging Tools At SIIM 2026
GE HealthCare (GEHC) plans to showcase new cloud-enabled enterprise imaging solutions at the SIIM 2026 Annual Meeting, aiming to capitalize on the shift towards cloud-based platforms for larger imaging datasets and AI-powered workflows. The company's stock has seen short-term gains but is down year-to-date, making the reception of these new offerings critical for its competitive positioning against rivals like Siemens Healthineers and Philips. Investors will be watching for concrete signals of adoption and revenue generation from these digital solutions, considering potential risks like cybersecurity concerns and the company's existing debt.
RBC Capital Initiates Coverage of GE HealthCare Technologies Inc. (GEHC)
RBC Capital has initiated coverage of GE HealthCare Technologies Inc. (GEHC) with an "Outperform" rating and an $80 price target, citing its attractive risk-reward profile, strong R&D spending, and solid order backlog. The company is poised for faster growth in late 2026 and recently showcased its new cloud-enabled enterprise imaging technologies at the SIIM 2026 Annual Meeting. GEHC specializes in medical technology, pharmaceutical diagnostics, and digital solutions.
